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42.1  IntroductIon
42.1.1  ClassifiCation, Morphology, and Biology
The genus Phialophora is a dematiaceous (dark-walled) fila-
mentous fungus belonging to the mitosporic Magnaporthaceae 
group, family Magnaporthaceae, order Magnaporthales, 
class Sordariomycetes, subphylum Pezizomycotina, phylum 
Ascomycota. The obsolete synonyms of the genus include 
Cadophora and Margarinomyces, and teleomorphs of this 
genus are found in Chaetosphaeria, Gaeumannomyces, and 
Mollisia.
Currently, the genus Phialophora contains 16 recog-
nized and over 69 unassigned species, the most notable of 
which are Phialophora bubakii, Phialophora europaea, 
Phialophora gregata, Phialophora repens (obsolete synonym 
Cadophora repens), Phialophora reptans, Phialophora 
richardsiae (obsolete synonyms: Cadophora brunnescens, 
Cadophora richardsiae, P. brunnescens, and P. calicifor-
mis), and Phialophora verrucosa (synonym: P. americana; 
obsolete synonym: Cadophora Americana; and teleomorph: 
Capronia semiimmersa) [1].
A number of former Phialophora species have been reclas-
sified: Phialophora compactum (synonym: Fonsecaea com-
pacta), Phialophora cyanescens (synonym: Cylindrocarpon 
cyanescens), Phialophora dermatitidis (synonyms: Exophiala 
dermatitidis and Wangiella dermatitidis), Phialophora hoff-
mannii (synonym: Lecythophora hoffmannii), Phialophora 
jeanselmei (synonym: Exophiala jeanselmei var. jeansel-
mei), Phialophora mutabilis (synonym: Lecythophora muta-
bilis), Phialophora parasitica (synonym: Phaeoacremonium 
parasiticum), Phialophora pedrosoi (synonym: Fonsecaea 
pedrosoi), and Phialophora spinifera (synonym: Exophiala 
spinifera).
Phialophora is a ubiquitous organism that inhabits the 
soil, plants, and decaying food [2,3]. Several Phialophora 
species are the causative agents of human infections such 
as chromoblastomycosis, phaeohyphomycosis, and eumy-
cetoma. P. verrucosa and P. richardsiae are often involved 
in phaeohyphomycosis, with clinical presentations rang-
ing from cutaneous infections, subcutaneous cysts, kerati-
tis, endocarditis, arthritis, osteomyelitis, cerebral infection, 
fatal hemorrhage, and disseminated infection. Phialophora 
verrucosa is the principal causative agent of chromoblas-
tomycosis in tropical and subtropical areas, particularly 
in Japan and South America. Phialophora europaea has 
been isolated from cutaneous and nail infections in North-
Western Europe.
Phialophora has short conidiophores (sometimes reduced 
to phialides) and unicellular conidia, although conidia are 
sometimes absent. Phialophora colonies grow moderately 
slowly and reach a diameter of 2–3 cm after 7 days at 25°C. 
Colonies are gray to olivaceous black and often become dark 
gray-green, brown, or black with age. From the reverse, colo-
nies appear iron-gray to black; colony texture is cottony to 
velvety and may be heaped and granular.
Phialophora hyphae (up to 5 μm wide) are branched and 
hyaline to brown. If present, condiophores are short and pale 
brown; conidiogenous cells (phialides) have characteristic 
flask-shaped or cylindrical phialides with distinctive collar-
ettes, which are terminally or laterally located on the hyphae; 
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conidia are one celled, hyaline to olivaceous brown, smooth 
walled, ovoid to cylindrical or allantoid, and often aggregate 
in slimy heads at the apices of the phialides, giving the appear-
ance of a vase of flowers; phialides may be solitary or in a 
brush-like arrangement. In tissues infected with Phialophora 
species, spherical or polyhedral, dark brown, thick-walled 
sclerotic bodies (muriform cells) and phaeoid hyphae are 
often present, although absence of muriform cells is noted in 
cases involving immunosuppressed or debilitated patients.
At the species level, Phialophora ripens produces inter-
calary phialides without basal septa or cylindrical to lageni-
form phialides (<20 μm in length) with narrow collarettes; 
Phialophora richardsiae conidia are globose to cylindrical 
and phialides with saucer- or vase-shaped collarettes; and 
Phialophora verrucosa produces flask-shaped phialides with 
vase-shaped collarettes; Phialophora europaea—a member 
of the P. verrucosa complex—shows reduced, flaring phi-
alidic collarettes [4].
42.1.2  CliniCal features and pathogenesis
The term dematiaceous (dark-pigmented) fungi refers to a 
large and heterogeneous group of molds belonging to sev-
eral different genera that are capable of causing a diverse 
range of clinical diseases such as phaeohyphomycosis, 
chromoblastomycosis, and eumycetoma. The most notable 
human pathogens in the dematiaceous fungal group include 
Alternaria, Bipolaris, Cladophialophora, Curvularia, 
Exophiala (Wangiella), Fonsecaea, Madurella, Phialophora, 
Rhinocladiella, Scedosporium, and Scytalidium. Being 
widely distributed in the environment including soil, wood, 
and decomposing plant debris, these organisms have the 
capacity to take advantage of weakened defense mecha-
nism of human hosts, inducing cutaneous, subcutaneous, 
and corneal infections, invasive and allergic sinusitis, arthri-
tis, endocarditis, and systemic and disseminated infections. 
Traumatic implantation, injury, and inhalation represent the 
main routes of entry, and host immune deficiency (suppres-
sion) plays a critical role in the development of systemic and 
disseminated infections [5,6].
Pheohyphomycosis affects the skin and subcutis, parana-
sal sinuses, or central nervous system and is often catego-
rized into four types by the region of the body in which the 
infection occurs: superficial, cutaneous, subcutaneous, and 
systemic [2]. Chromoblastomycosis is a cutaneous and subcu-
taneous mycotic disease (mostly of the feet and legs) with the 
appearance of pigmented sclerotic bodies, commonly called 
“copper pennies” [5]. Eumycetoma is a subcutaneous fungal 
infection (mostly of the feet and legs) showing a mass with 
multiple sinuses draining pus and “grains.” The grains (0.5–
1.5 mm in diameter) in eumycetoma may appear white (due 
to infection with Acremonium, Cylindrocarpon, Fusarium, 
Neotestudina, or Pseudallescheria) or black (due to infection 
with Exophiala, Madurella, Leptosphaeria, Pyrenochaeta, 
or Phlenodomus).
Phialophora spp. have been shown to cause chromo-
blastomycosis, mycotic keratitis, cutaneous infections, 
osteomyelitis, and prosthetic valve endocarditis as well 
as disseminated infections [7–13], with P. verrucosa and 
P. richardsiae being most commonly reported [9,14–17].
42.1.2.1  Phialophora verrucosa
A case of fatal hemorrhage due to Phialophora verrucosa 
occurred in a patient with prolonged neutropenia undergo-
ing autologous bone marrow transplant (BMT) for acute 
myelogenous leukemia (AML). Autopsy uncovered granula-
tion tissue on the tracheal wall, which showed fungal hyphae 
by histopathological examination and grew P. verrucosa in 
culture [18].
In a case of Phialophora verrucosa-related multifocal 
subcutaneous phaeohyphomycosis, an 85 year-old woman 
presented with purulent multifocal subcutaneous nodules 
on the right forearm and hand. The patient reported a his-
tory of gardening and recalled the occurrence of a painless, 
soybean-sized nodule on the dorsal site of the right forearm 
3 years earlier, which gradually extended peripherally to the 
dorsum of the right hand. The pustules and nodules (rang-
ing from 5 × 5 mm to 20 × 40 mm in size) showed a yellow 
crust on the surface and were surrounded by erythema and 
discharged a purulent fluid upon pressure. Examination of 
the biopsied specimen revealed a subcutaneous granuloma 
(containing faint brown septate hyphae with rare branching) 
with central abscess and necrosis, consistent with phaeomy-
cotic cyst. Culture of the discharged purulent fluid on potato 
dextrose agar (PDA) at room temperature grew a nearly black 
fungus, attaining a diameter of 20 mm in 14 days and 50 mm 
in 35 days. Under light microscope, flask-shaped phialides 
(conidiogenous cells) with cup-shaped collarettes and a 
bunch of elliptical conidia at the apices of the collarettes 
were noted along with brown to light-brown hyphae. These 
morphologic features confirmed the fungus as P. verrucosa, 
which responded to oral itraconazole treatment [19].
A cutaneous fungal infection due to P. verrucosa was 
reported in a 53 year-old woman who had a history of sys-
temic corticosteroid treatment for Evans’ syndrome. The 
patient presented asymptomatic multiple nodules on her glu-
teal region. A smear from the purulent exudate of the nodules 
showed brown-colored hyphae, spores, and large dark-brown 
cells; and a dark-brown-colored colony grew on Sabouraud 
glucose agar, showing Phialophora-type conidia formation. 
The fungus was diagnosed as Phialophora verrucosa [20].
Phialophora verrucosa was also shown to be responsible 
for a severe, verrucous facial mycosis and sinusitis in a 12 
year-old girl. The disease began with the development of 
verrucous, hyperkeratotic plaques, and subcutaneous violet 
nodules on face and upper extremities and later evolved into 
severely progressive tumorous cutaneous and nasal lesions. 
Microscopic examination of scale samples from the upper 
extremities and the face showed brown, thick-walled fungal 
elements, which were subsequently identified as Phialophora 
verrucosa. Oral treatment with itraconazole and fluorocyto-
sin resulted in significant improvement of the lesions [17].
A case of polymicrobial keratitis caused by Phialophora 
verrucosa, Candida tropicalis, and Propionibacterium acnes 
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has also been described. Histopathologic evaluation revealed 
penetration of the crystalline lens by fungus at the site of 
synechiae between the intact lens capsule and iris [13].
42.1.2.2  Phialophora richardsiae
A case of subcutaneous phaeohyphomycosis due to 
Phialophora richardsiae was described in renal transplant 
recipient. The patient developed dark-colored nodules that 
subsequently ulcerated after transplantation. Histopathologic 
examination showed dematiaceous fungal hyphae with a sur-
rounding granulomatous reaction, and the fungus was identi-
fied as P. richardsiae [21].
Diseases due to dematiaceous fungi require antifun-
gal and surgical treatments. Current antifungal therapy for 
chromoblastomycosis and subcutaneous phaeohyphomycosis 
relies on itraconazole, and for eumycetoma is ketoconazole. 
Surgical debridement in combination with amphotericin B 
treatment is useful for chronic invasive sinusitis [6,9].
42.1.3  laBoratory diagnosis
Phialophora represents one of the dematiaceous fungi 
responsible for causing phaeohyphomycosis and chromoblas-
tomycosis in humans. There is a need to differentiate among 
the other dematiaceous fungi in order to implement appropri-
ate treatment regimens as these organisms demonstrate var-
ied sensitivity to the currently available antifungal drugs [6].
Dematiaceous fungi including Phialophora spp. have 
been traditionally identified by macroscopic and microscopic 
characteristics as well as biochemical properties. For exam-
ple, phospholipase production, induced by egg yolk substrate, 
offers a useful means for the differentiation of the taxonomi-
cally related dematiaceous fungal species on the basis of their 
distinct enzymatic profiles [22]. Nevertheless, these methods 
are laborious and sometimes incapable of distinguishing spe-
cies with polymorphic conidiogeneses or lacking conidia 
formation.
For these reasons, molecular techniques such as random 
amplified polymorphic DNA (RAPD), restriction fragment 
length polymorphism (RFLP), and DNA sequencing have 
been adopted increasingly for identification [23]. In particu-
lar, sequencing analysis of small subunit (SSU) 18S and large 
subunit (LSU) 28S rRNA genes and internal transcribed 
spacer regions (ITS) has proven valuable. Indeed, many 
Phialophora species can be correctly identified by examin-
ing the nucleotide sequence of the D1/D2 domains in the 28S 
rRNA gene [24].
42.2  Methods
42.2.1  saMple preparation
Clinical specimens suspected of containing dematiaceous 
fungi are treated with 10% KOH or stained with calcofluor 
white and observed by microscopy for septate hyphal ele-
ments. Samples are then inoculated onto inhibitory mold 
agar, modified Sabouraud agar, or PDA at 25°C, 35°C, and 
50°C, respectively. Preliminary identification of the colonies 
is based on macroscopic and microscopic features [25].
After the growth for 1–7 days on PDA slants, approxi-
mately 1 cm2 of mycelium is collected by scraping the slant 
with a sterile stick that is placed in 1 mL of sterile H2O. The 
material is transferred to a 2 mL screw-cap tube, and the tube 
is centrifuged for 1 min at 6000 × g. If the mycelium does not 
pellet, the material is passed through a pediatric blood serum 
filter. After removal of the supernatant, the material is resus-
pended in 200 μL of IDI sample buffer (IDI lysis kit, BD) and 
transferred to the lysis tube containing glass beads. The lysis 
tube is vortexed on the highest setting for 5 min, and the tube 
is placed in a boiling water bath for 15 min. Following cen-
trifugation for 5 min at 16,000 × g, the supernatant is stored at 
−20°C until PCR is undertaken [25].
Alternatively, about 1 cm2 of fungal material is transferred 
to a 2 mL Eppendorf tube containing a 2:1 (wt/wt) mixture 
of silica gel and Celite (silica gel H, Merck 7736/Kieselguhr 
Celite 545; Machery) and 300 μL of TES buffer (2 g Tris 
[hydroxymethyl]-aminomethane, 0.38 g Na-EDTA, and 2 g 
sodium dodecyl sulfate in 80 mL of ultrapure water pH 8). 
The fungal material is ground with a micropestle for 1–2 min. 
The volume is adjusted by adding 200 μL of TES buffer. 
After vigorous shaking and the addition of 10 μL of a 10 mg/
mL concentration of proteinase K to the tube, the mixture is 
incubated at 65°C for 10 min. With the addition of 140 μL of 
5 M NaCl solution, the mixture is combined with 1/10 vol-
ume (∼65 μL) of cetyltrimethylammonium bromide (CTAB) 
buffer 10%, followed by incubation for another 30 min at 
65°C. One volume (∼700 μL) of chloroform– isoamyl alcohol 
(vol/vol = 24/l) is added and mixed by inversion. After incu-
bation for 30 min at 0°C (on ice water) and centrifugation at 
14,000 rpm at 4°C for 10 min, the top layer is transferred to 
a clean Eppendorf tube. The sample is added with 225 μL 
of 5 M NH4–acetate and incubated for at least 30 min (on 
ice water) and centrifuged. The supernatant is transferred to 
a clean sterile Eppendorf tube and mixed with a 0.55 vol-
ume (∼510 μL) of ice-cold isopropanol. After centrifugation 
for 7 min at 14,000 rpm and 4°C (or room temperature), the 
supernatant is decanted. The pellet is washed with ice-cold 
ethanol 70% twice and air dried. The powder is resuspended 
in 48.5 μL of Tris–EDTA buffer with 1.5 μL of 10 mg of 
RNase/mL, incubated at 37°C for 15–30 min, and stored at 
−20°C until use [26].
In addition, fungal strains can be cultured in 20 mL of 
RPMI 1640 medium with l-glutamine but without sodium 
bicarbonate (Sigma-Aldrich) buffered to pH 7.0 with 0.165 M 
morpholinepropanesulfonic acid (MOPS) (Sigma-Aldrich). 
After 3–14 days of growth with agitation at 30°C (100 rpm), 
the mycelium is transferred into a tube and washed in 40 mL 
of sterile distilled water. Mycelium is then stored at −20°C 
until use. For DNA extraction, 100 mg of mycelium is homog-
enized for 1 min in a tube containing 1 mL of lysis buffer (2% 
Triton X-100, 1% sodium dodecyl sulfate, 10 mM Tris–HCl 
pH 8, 100 mM NaCl, and 1 mM EDTA pH 8), three 0.5 cm 
diameter glass beads (Sigma), and approximately 500 mg 
of 425–600 μm glass beads (Sigma). The homogenized 
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mycelium is snap-frozen in liquid nitrogen, thawed, and 
refrozen once. DNA is then extracted using a DNeasy plant 
kit (Qiagen) [27].
Also, fungal DNA may be prepared by suspending 50 mg 
of mycelium in 600 μL extraction buffer (200 mM Tris–HCl, 
pH 7.5, 25 mM EDTA, 0.5% w/v sodium dodecyl sulfate, and 
250 mM NaCl). The mixture is vortexed for 15 s, incubated 
at 100°C for 15 min, kept on ice for 60 min, and then centri-
fuged at 14,000 × g for 15 min. Supernatants are transferred 
to new tubes and extracted with phenol–chloroform–isoamyl 
alcohol (25:24:1 v/v). Each sample DNA is precipitated with 
cold isopropanol (−20°C), dried, and resuspended in 100 μL 
distilled water [24].
42.2.2  deteCtion proCedures
42.2.2.1   Pan-Fungal real-time Pcr and 
sequencing Analysis
Pounder [25] reported a real-time PCR with SYBR green 
DNA-binding dye and amplicon-melting temperature anal-
ysis for fungal detection using pan-fungal primers ITS1 
forward (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 
reverse (5′-TCCTCCGCTTATTGATATGC-3′) [28]. The 
identity of the fungus is confirmed by sequencing.
Procedure
 1. PCR mixture consists of 1 × Lightcycler FastStart 
DNA Master Hybridization Probes mixture (Roche 
Applied Science) containing deoxynucleoside tri-
phosphates, FastStart Taq DNA polymerase, and 
1 mM MgCl2 (additional MgCl2 is added to a final 
concentration of 4.6 mM), 0.4 μM each of ITS1 for-
ward and ITS4 reverse primers, 1 × SYBR green 
(Molecular Probes), and 3 μL template DNA.
 2. Thermal cycling parameters include 95°C for 
10 min; 50 cycles of 95°C for 5 s, 60°C for 20 s, and 
72°C for 30 s; and a final 72°C for 2 min.
 3. The quality of the amplicon is determined using the 
derivative of the melt analysis curve (55°C–99°C, 
45 s hold at 55°C, and 5 s/°C) using the RotorGene 
3000 (Corbett Robotics, Inc).
 4. The amplified product is purified for bidirectional 
sequencing using ExoSAP-IT (USB Corp). Five 
microliters of Big Dye Terminator Ready Reaction 
Mix v. 1.1 (Applied Biosystems) is added to 4 μL of 
each primer (0.8 pmol/μL) and 3 μL of purified PCR 
product. Cycle sequencing is performed with a 9700 
thermal cycler (ABI), using 25 cycles of 96°C for 
10 s, 50°C for 5 s, and 60°C for 4 min. Sequencing 
reaction products are passed through a Sephadex 
G-50 fine column to remove unincorporated dye ter-
minators. Purified sequencing reaction products are 
run on an ABI Prism 3100 Genetic Analyzer with a 
50 cm capillary array.
 5. Sequences are analyzed with the SmartGene 
Integrated Database Network software version 
3.2.3 vr. SmartGene is a web-based software and 
database system with reference sequences derived 
from the National Center for Biological Information 
(NCBI) GenBank repository.
Note. Sequence-based identifications are defined by percent 
identity: species, ≥99%; genus, 93%–99%; and inconclusive, 
≤93%.
42.2.2.2   sequencing Analysis of the 
Its1-5.8s-Its2 region
Zeng et al. [26] utilized primers V9G (5′-TTA CGT CCC 
TGC CCT TTG TA-3′) and LS266 (5′-GCAT TCC CAA 
ACA ACT CGA CTC-3′) for PCR amplification and sequence 
analysis of the ITS-5.8S-ITS2 region.
Procedure
 1. PCR mixture (50 μL) is composed of 10 mM Tris–
HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl · 6H2O, 
0.01% gelatin, 200 mM of each dNTP, 25 pmol of 
each primer, 0.5 U of Taq DNA polymerase (Sigma), 
and 10–100 ng of extracted DNA.
 2. The mixture is subjected to an initial 95°C for 
4 min, 35 cycles of 94°C for 45 s, 52°C for 30 s, 
and 72°C for 2 min, and a final 72°C for 7 min in a 
GenAmp PCR System 9700 thermocycler (Applied 
Biosystems).
 3. Amplicons are purified with GFX columns (GE 
Healthcare), and both strands are sequenced with 
each of the two primers separately. The sequenc-
ing PCR mixture consists of 1 μL of template DNA 
(1–10 ng), 3 μL of dilution buffer, 1 μL of BigDye 
v3.1, and 1 μL of 4 pmol primer filled with 4 μL of 
MilliQ water to a final volume of 10 μL. The ampli-
fication is performed with initial 95°C for 1 min, 30 
cycles of 95°C for 10 s, 50°C for 5 s, and 60°C for 
2 min. Reaction products are cleaned with Sephadex 
G-50 Fine (GE Healthcare Bio-Sciences) and ana-
lyzed by using an ABI Prism 3730xl DNA analyzer 
(Applied Biosystems).
 4. The sequences are adjusted by using the Lasergene 
software program SeqMan Π (DNASTAR, Inc.) 
and aligned iteratively using Ward’s averaging in 
the Bionumerics package v. 4.0 (Applied Maths). 
Nearest neighbors are identified by local BLAST 
searches. The distance trees are based on a realigned 
file using the DCSE program and calculated by the 
neighbor-joining (NJ) method of the Treecon pack-
age with Kimura-2 correction; only unambiguously 
aligned positions are taken into account. A total 
of 100 bootstrap replicates are used for analysis. 
Bootstrap values of >90 from 100 resampled datas-
ets are shown.
Note. If the similarity of sequences of the ITS region is more 
than 99% between a studied strain and its nearest neighbor 
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and they are distributed in the same branch of the phyloge-
netic tree, the strain is regarded as belonging to the same 
species as its nearest neighbor.
42.2.2.3   sequencing Analysis of the d1/ d2 
domains of 28s rrnA Gene
Abliz et al. [24] utilized primers NL-1 (5′-GCATATCAAT 
AAGCGGAGGAAAAG-3′) and NL-4m (5′-GGTCC 
GTGTTTCAAGACG-3) to amplify the conserved D1/ D2 
domains of the 28S rRNA from Phialophora and other 
dematiaceous fungi. Subsequent analysis of the ampli-
con with primers NL-1 and NL-4m and internal primers 
NL-2m (5′-CTTGTGCGCTATCGGTCTC-3′) and NL-3m 
(5′-GAGACCGATAGCGCACAAG-3′) permitted the correct 
identification of Phialophora spp.
Procedure
 1. PCR mixture (50 μL) is made up of 5 μL of tem-
plate DNA, 5 μL (2 pmol) each of primers NL-1 
and NL-4m, 4 μL (2.5 mM) dNTP mixture, 0.25 μL 
(5 U/μL) Taq polymerase, and 5 μL 10 × reaction 
buffer.
 2. Amplification is conducted with an initial 95°C for 
4 min; 30 cycles of 94°C for 1 min, 55°C for 2.5 min, 
and 72°C for 2.5 min; and a final 72°C for 10 min.
 3. The amplified products are first checked on 1.5% 
agarose gel, purified with SUPREC™-02 (TaKaRa) 
and sequenced with an ABI Prism 3100 sequencer 
after labeling with BigDye™ Terminator Cycle 
Sequencing Ready Reaction (Applied Biosystems) 
using external primers, NL-1 and NL-4m, and the 
internal primers, NL-2m and NL-3m.
 4. The sequence data are aligned with CLUSTAL W 
(version 1.6). Phylogenetic trees are constructed 
with the NJ method.
42.3  conclusIon
The genus Phialophora is a dematiaceous fungus that rep-
resents one of the causes for human phaeohyphomycosis 
and chromoblastomycosis. The most common Phialophora 
spp. identified in human infections are P. verrucosa and 
P. richardsiae, with clinical symptoms ranging from cutane-
ous and subcutaneous infections, mycotic keratitis, osteomy-
elitis, endocarditis, and disseminated infections.
Because different dematiaceous fungal genera/species 
demonstrate varied sensitivity and resistance to antifungal 
reagents, it is important to determine their species identity 
with the aim of implementing most effective treatment mea-
sures for these diseases [6]. While traditional macroscopic, 
microscopic, and biochemical methods provide a useful 
approach for the differentiation of the taxonomically related 
dematiaceous Phialophora spp., they suffer from the short-
comings of being time consuming, laborious, and incapable 
of distinguishing species with polymorphic conidiogeneses 
or lacking conidia. Exploiting the nucleotide variations 
within the ITS by PCR followed by sequencing offers a 
valuable tool for precise determination of Phialophora 
species.
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